Bluepoint Partners has secured a 10 billion KRW investment from Jet Venture Capital and Inbody to enhance its deep tech portfolio and foster strategic partnerships within the startup ecosystem.
Target Information
Bluepoint Partners has successfully raised a substantial investment of 10 billion KRW aimed at enhancing the quality of early-stage investments. This funding round features participation from Jet Venture Capital (ZVC) and global healthcare company Inbody, each contributing 5 billion KRW to the round. However, the precise valuation of this investment round remains undisclosed.
The funds acquired will be strategically allocated to discover and nurture startups that possess global competitiveness, and bolster the processes associated with technology commercialization. This investment is not merely a financial boost; it is aimed at strengthening strategic partnerships with these notable investors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in South Korea
The deep tech industry in South Korea is experiencing rapid growth, driven by advancements in technology sectors such as quantum computing, AI, and bio-health. Recent trends indicate
Similar Deals
Smilegate Investment, MY Social Company (MYSC) → JamJam Therapeutics
2023
ZVC, InBody
invested in
Bluepoint Partners
in 2025
in a Other VC deal
Disclosed details
Transaction Size: $8M